by Jared Friedman11/6/2025

Today, BillionToOne goes public, becoming YC's fourth publicly traded biotech company. More importantly, they have built one of the most important genetic tests in the U.S. Today, 1 in 11 babies born in the US are tested with BillionToOne's fetal genetic test.

by Harj Taggar10/14/2025

We're excited to announce that nine exceptional founders are joining us as Visiting Partners at YC: Matt Riley, Harshita Arora, Grey Baker, Christopher Golda, Raphael Schaad, Christina Gilbert, Francois Chaubard, Vivian Shen, and James Evans.

by Harj Taggar, Jesse Pollak9/23/2025

We are entering the era of Fintech 3.0. Regulatory clarity, growing consumer adoption, and low-cost chains have paved the way for a golden age of building in crypto — and at YC, Base, and Coinbase, we want to fund builders to seize this moment.

by Garry Tan9/12/2025

We’re thrilled to announce that Ankit Gupta is joining YC as our newest General Partner.

by Garry Tan6/12/2025

After 12+ years, 25 batches, and working with more than a thousand startups, Dalton Caldwell is transitioning to Partner Emeritus at YC.

by Garry Tan5/21/2025

Over the last few batches, visiting partners Jon Xu and Andrew Miklas have become two of the most trusted voices in the YC community. They were both founders in YC’s Summer 2010 batch, and now, 15 years and two industry-shaping companies later, they’re back in a new role: General Partners at YC.

by Garry Tan4/1/2025

We’re thrilled to welcome Tyler Bosmeny back to YC, this time as a General Partner.